Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$650M |
| 2 |
Advanced Micro Devices
AMD
|
+$503M |
| 3 |
Meta Platforms (Facebook)
META
|
+$386M |
| 4 |
Accenture
ACN
|
+$343M |
| 5 |
Cognizant
CTSH
|
+$342M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$895M |
| 2 |
Adobe
ADBE
|
+$597M |
| 3 |
Microsoft
MSFT
|
+$459M |
| 4 |
Apple
AAPL
|
+$449M |
| 5 |
Nike
NKE
|
+$444M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.25% |
| 2 | Healthcare | 14.09% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Financials | 9.74% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
FuelCell Energy
FCEL
$1.7B
| $3.6M | ﹤0.01% |
55,268
-1,261
| -2% | -$85.6K |
|
1002
Woodward
WWD
$25B
| $3.59M | ﹤0.01% |
30,304
+26,283
| +654% | +$2.78M |
|
1003
ScottsMiracle-Gro
SMG
$4.03B
| $3.5M | ﹤0.01% |
54,257
-89,716
| -62% | -$6.02M |
|
1004
NovoCure
NVCR
$2.04B
| $3.47M | ﹤0.01% |
81,944
-140,754
| -63% | -$8.74M |
|
1005
Silicon Laboratories
SLAB
$7.15B
| $3.46M | ﹤0.01% |
21,565
-11,982
| -36% | -$1.81M |
|
1006
Doximity
DOCS
$3.67B
| $3.44M | ﹤0.01% |
104,605
-20,523
| -16% | -$683K |
|
1007
Coupang
CPNG
$27.8B
| $3.39M | ﹤0.01% |
195,738
+669
| +0.3% | +$10.9K |
|
1008
Brookfield Asset Management
BAM
$74B
| $3.38M | ﹤0.01% |
103,388
+12,232
| +13% | +$393K |
|
1009
Adtran
ADTN
$798M
| $3.35M | ﹤0.01% |
316,609
+242,190
| +325% | +$2.4M |
|
|
HFRO
1010
Highland Opportunities and Income Fund
HFRO
$407M
| $3.34M | ﹤0.01% |
367,181
| – | – |
|
1011
Sony
SONY
$123B
| $3.3M | ﹤0.01% |
180,445
-1,380
| -0.8% | -$25.9K |
|
1012
Box
BOX
$4.02B
| $3.25M | ﹤0.01% |
110,582
+56,948
| +106% | +$1.58M |
|
|
APLS
1013
DELISTED
Apellis Pharmaceuticals
APLS
| $3.22M | ﹤0.01% |
36,104
-769
| -2% | -$66.3K |
|
|
SPWR
1014
DELISTED
SunPower Corporation Common Stock
SPWR
| $3.21M | ﹤0.01% |
325,985
-42,365
| -12% | -$494K |
|
1015
Rayonier
RYN
$6.49B
| $3.21M | ﹤0.01% |
112,978
| – | – |
|
1016
PennyMac Financial
PFSI
$4.38B
| $3.21M | ﹤0.01% |
45,735
-11,905
| -21% | -$754K |
|
|
RWT
1017
Redwood Trust
RWT
$616M
| $3.21M | ﹤0.01% |
503,191
-1,842
| -0.4% | -$11.5K |
|
1018
Omnicell
OMCL
$1.86B
| $3.2M | ﹤0.01% |
+43,828
| New | +$2.96M |
|
1019
Algonquin Power & Utilities
AQN
$4.69B
| $3.2M | ﹤0.01% |
376,526
+98,389
| +35% | +$836K |
|
1020
iShares MSCI Poland ETF
EPOL
$669M
| $3.17M | ﹤0.01% |
163,700
-51,500
| -24% | -$915K |
|
|
AOMR
1021
Angel Oak Mortgage REIT
AOMR
$219M
| $3.16M | ﹤0.01% |
389,849
+3,447
| +0.9% | +$26.6K |
|
1022
Independence Realty Trust
IRT
$3.92B
| $3.14M | ﹤0.01% |
170,139
+7,596
| +5% | +$130K |
|
1023
Phillips Edison & Co
PECO
$5.48B
| $3.1M | ﹤0.01% |
90,516
-8,093
| -8% | -$253K |
|
1024
iShares MSCI Taiwan ETF
EWT
$10B
| $3.07M | ﹤0.01% |
64,500
| – | – |
|
1025
iShares MSCI Emerging Markets ETF
EEM
$28B
| $3.04M | ﹤0.01% |
76,000
-533,500
| -88% | -$21M |
|
Similar funds
Amundi's Q2 2023 Portfolio in Review
As of Q2 2023, Amundi held 2,165 positions worth $198B, up 6.6% from $186B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Amundi's Q2 2023 filing shows 120 new, 691 increased, 902 reduced and 140 closed positions. Its largest new stake was Clean Harbors: 361,151 shares worth $58.9M. The largest sale was UnitedHealth, an estimated $895M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Amundi's largest Q2 2023 buy was Clean Harbors: 361,151 shares worth $58.9M.
- Amundi added most to Wells Fargo 7.5% Non Cumv Perp Conv in Q2 2023, an estimated $650M increase.
- Amundi's biggest Q2 2023 reduction was UnitedHealth, cutting an estimated $895M.
- Amundi fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $111M.
- Amundi's ten largest holdings make up 22% of its $198B portfolio in Q2 2023.
- Amundi opened 120 new positions and closed 140 in Q2 2023.
- Amundi's portfolio value rose 6.6% quarter-over-quarter to $198B.
Based on Amundi's 13F filing for Q2 2023, filed 14 Aug 2023.